BAYERCROP — Bayer Cropscience Income Statement
0.000.00%
- IN₹149.04bn
- IN₹143.84bn
- IN₹56.75bn
Annual income statement for Bayer Cropscience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 47,344 | 51,397 | 51,032 | 54,734 | 56,750 |
| Cost of Revenue | |||||
| Gross Profit | 20,356 | 22,726 | 21,420 | 20,212 | 22,392 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Operating Interest Expense / Income | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 39,187 | 41,813 | 42,118 | 48,543 | 48,822 |
| Operating Profit | 8,157 | 9,584 | 8,914 | 6,191 | 7,928 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 8,468 | 9,901 | 9,414 | 7,074 | 8,549 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6,453 | 7,582 | 7,405 | 5,680 | 6,892 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6,453 | 7,582 | 7,405 | 5,680 | 6,892 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6,453 | 7,582 | 7,405 | 5,680 | 6,892 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 134 | 151 | 169 | 122 | 149 |
| Dividends per Share | |||||
| Special Dividends per Share |